Mark J. Foley

Insider Reports History

Entity
Individual
Location
Zeltiq Aesthetics Inc., 4698 Willow Road Suite 100, Pleasanton, California
Signature
/s/ Dwight Moxie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark J. Foley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. CEO, Director Performance Stock Units 1.07M $7.99M $7.47 Jan 31, 2024 Direct
GLAUKOS Corp Director Common Stock 34.9K $3.97M $113.68 May 30, 2024 Direct
Revance Therapeutics, Inc. CEO, Director Common Stock 996K $2.18M $2.18 Jun 30, 2024 Direct
Revance Therapeutics, Inc. CEO, Director Common Stock 111K $242K $2.18 Jun 30, 2024 Indirect
GLAUKOS Corp Director Stock Option (Right to Buy) 1.25K $86.3K $69.30 May 30, 2024 Direct

Insider Reports Filed by Mark J. Foley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVNC Revance Therapeutics, Inc. Jun 30, 2024 1 $2.18K 4 Jul 2, 2024 CEO, Director
GKOS GLAUKOS Corp May 30, 2024 2 $0 4 Jun 3, 2024 Director
RVNC Revance Therapeutics, Inc. Mar 15, 2024 2 -$109K 4 Mar 19, 2024 CEO, Director
RVNC Revance Therapeutics, Inc. Mar 6, 2024 1 $209K 4 Mar 8, 2024 CEO, Director
RVNC Revance Therapeutics, Inc. Feb 29, 2024 1 $0 4 Mar 4, 2024 CEO, Director
GKOS GLAUKOS Corp Feb 23, 2024 3 -$351K 4 Feb 26, 2024 Director
RVNC Revance Therapeutics, Inc. Jan 31, 2024 1 $0 4 Feb 2, 2024 CEO, Director
RVNC Revance Therapeutics, Inc. Dec 31, 2023 1 $1.97K 4 Jan 3, 2024 CEO, Director
RVNC Revance Therapeutics, Inc. Aug 11, 2023 2 -$909K 4 Aug 15, 2023 CEO, Director
RVNC Revance Therapeutics, Inc. Aug 3, 2023 1 -$593K 4 Aug 4, 2023 CEO, Director
RVNC Revance Therapeutics, Inc. Jun 30, 2023 2 -$640K 4 Jul 5, 2023 CEO, Director
RVNC Revance Therapeutics, Inc. Jun 9, 2023 1 -$961K 4 Jun 13, 2023 CEO, Director
GKOS GLAUKOS Corp Jun 1, 2023 1 $0 4 Jun 5, 2023 Director
RVNC Revance Therapeutics, Inc. Mar 15, 2023 1 -$164K 4 Mar 17, 2023 CEO, Director
GKOS GLAUKOS Corp Jan 3, 2023 1 $0 4 Jan 4, 2023 Director
RVNC Revance Therapeutics, Inc. Dec 31, 2022 1 $7.37K 4 Jan 3, 2023 CEO, Director
RVNC Revance Therapeutics, Inc. Oct 13, 2022 1 -$1.33M 4 Oct 14, 2022 CEO, Director
RVNC Revance Therapeutics, Inc. Sep 22, 2022 2 -$2.22M 4 Mar 9, 2023 CEO, Director
RVNC Revance Therapeutics, Inc. Jun 30, 2022 1 $11.7K 4 Jul 5, 2022 CEO, Director
GKOS GLAUKOS Corp Jun 2, 2022 1 $0 4 Jun 6, 2022 Director
RVNC Revance Therapeutics, Inc. Mar 15, 2022 1 -$52.2K 4 Mar 17, 2022 Chief Executive Officer, Director
RVNC Revance Therapeutics, Inc. Feb 2, 2022 2 -$2.43M 4 May 16, 2023 CEO, Director
RVNC Revance Therapeutics, Inc. Feb 2, 2022 1 $0 4 Feb 4, 2022 CEO, Director
GKOS GLAUKOS Corp Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
RVNC Revance Therapeutics, Inc. Nov 29, 2021 1 $516K 4 Nov 29, 2021 CEO, Director
RVNC Revance Therapeutics, Inc. Oct 13, 2021 1 -$972K 4 Oct 15, 2021 CEO & President, Director
RVNC Revance Therapeutics, Inc. Jun 30, 2021 1 $21.2K 4 Jul 2, 2021 CEO & President, Director
GKOS GLAUKOS Corp Jun 3, 2021 1 $0 4 Jun 7, 2021 Director